Jessica Tassan
Stock Analyst at Piper Sandler
(1.81)
# 3,278
Out of 5,050 analysts
86
Total ratings
33.85%
Success rate
-8.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PINC Premier | Maintains: Neutral | $28 → $28 | $28.15 | +0.36% | 9 | Nov 5, 2025 | |
| HNGE Hinge Health | Reiterates: Overweight | $70 → $71 | $44.49 | +59.59% | 2 | Nov 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $423 → $417 | $324.21 | +28.62% | 9 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $22.02 | +54.41% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $4.96 | +262.90% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $2.83 | +41.34% | 12 | Aug 27, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $69.25 | +24.19% | 3 | Aug 15, 2025 | |
| OSCR Oscar Health | Maintains: Neutral | $14 → $13 | $17.72 | -26.64% | 6 | Aug 14, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $54.29 | +27.10% | 4 | Aug 11, 2025 | |
| HUM Humana | Maintains: Neutral | $288 → $272 | $252.04 | +7.92% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $10 → $8 | $4.21 | +90.02% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $264.58 | +41.36% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $72 → $74 | $78.99 | -6.32% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $16.33 | +28.60% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $7.53 | +59.36% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $35.68 | +96.19% | 4 | Aug 2, 2023 |
Premier
Nov 5, 2025
Maintains: Neutral
Price Target: $28 → $28
Current: $28.15
Upside: +0.36%
Hinge Health
Nov 5, 2025
Reiterates: Overweight
Price Target: $70 → $71
Current: $44.49
Upside: +59.59%
UnitedHealth Group
Oct 29, 2025
Maintains: Overweight
Price Target: $423 → $417
Current: $324.21
Upside: +28.62%
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $22.02
Upside: +54.41%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $4.96
Upside: +262.90%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $2.83
Upside: +41.34%
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $69.25
Upside: +24.19%
Oscar Health
Aug 14, 2025
Maintains: Neutral
Price Target: $14 → $13
Current: $17.72
Upside: -26.64%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $54.29
Upside: +27.10%
Humana
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $252.04
Upside: +7.92%
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $4.21
Upside: +90.02%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $264.58
Upside: +41.36%
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $78.99
Upside: -6.32%
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $16.33
Upside: +28.60%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.53
Upside: +59.36%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $35.68
Upside: +96.19%